Adaptive Biotechnologies Corp

Maps immune genetics for blood cancer diagnostics and drug discovery partnerships.

ADPT | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 1165 EASTLAKE AVE E, 98109 SEATTLE
Website:: https://www.adaptivebiotech.com
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Adaptive Biotechnologies is a commercial-stage biotechnology company pioneering the field of immune medicine. The company's proprietary Immune Medicine Platform maps the genetics of the adaptive immune system by sequencing T-cell and B-cell receptors at scale. This technology enables two primary application areas: clinical diagnostics and drug discovery. Its key diagnostic product is a highly sensitive, next-generation sequencing (NGS)-based assay for the assessment of Minimal Residual Disease (MRD) in blood cancers, used in both clinical practice and drug trials. Additionally, Adaptive partners with pharmaceutical companies, providing rich immune receptor data and services to inform clinical trials and support the development of new therapeutics.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Adaptive Biotechnologies Corp filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Adaptive Biotechnologies Corp

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Adaptive Biotechnologies Corp via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
BRAIN Biotech AG Develops custom enzymes and microbes for the food, nutrition, and chemical industries.	Germany	BNN
Branding Technology Inc. Drives digital transformation for SMEs with data-driven digital marketing and brand development.	Japan	7067
BriaCell Therapeutics Corp. Develops off-the-shelf cellular immunotherapies for advanced breast, prostate, and lung cancers.	United States of America	BCTX
BrightBid Group AI SaaS platform automating paid search & shopping ads for businesses to maximize ROI.	Sweden	BRIGHT
BrightPath Biotherapeutics Co., Ltd. Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.	Japan	4594
Brilliant Future AB A data-driven survey platform to measure and improve employee & customer experiences.	Sweden	BRILL
b-style holdings,Inc. Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.	Japan	302A
BTS Group Helps organizations execute strategy via experiential learning for leadership and sales teams.	Sweden	BTS
B.U Technology Commercializes university research via IP management, licensing, and new venture creation.	South Korea	230980
Camino Minerals Corporation Advancing high-grade copper and precious metal projects from discovery to production.	Canada	COR